U
Renovare Environmental, Inc.
RENO
$0.00
$0.000.00%
E
Sell
3/14/2023Downgrade
Renovare Environmental, Inc. (RENO) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
Renovare Environmental, Inc. (RENO) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Renovare Environmental, Inc. (RENO) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
Renovare Environmental, Inc. (RENO) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Renovare Environmental, Inc. (RENO) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.03 to 0.02, and debt to equity increased from -2.78 to -2.42.
Renovare Environmental, Inc. (RENO) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.03 to 0.02, and debt to equity increased from -2.78 to -2.42.
D
Sell
5/5/2022Upgraded
Renovare Environmental, Inc. (RENO) was upgraded to D- from E+ on 05/05/2022.
Renovare Environmental, Inc. (RENO) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
Renovare Environmental, Inc. (RENO) was downgraded to E+ from D- on 04/20/2022.
Renovare Environmental, Inc. (RENO) was downgraded to E+ from D- on 04/20/2022.
D
Sell
4/18/2022Downgrade
Renovare Environmental, Inc. (RENO) was downgraded to D- from D on 4/18/2022 due to a noticeable decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.0697 to -$0.5836, EBIT declined 104.53% from -$1.15M to -$2.35M, and the quick ratio declined from 0.14 to 0.03.
Renovare Environmental, Inc. (RENO) was downgraded to D- from D on 4/18/2022 due to a noticeable decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.0697 to -$0.5836, EBIT declined 104.53% from -$1.15M to -$2.35M, and the quick ratio declined from 0.14 to 0.03.
D
Sell
11/9/2021Upgraded
BioHiTech Global, Inc. (BHTG) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
BioHiTech Global, Inc. (BHTG) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
BioHiTech Global, Inc. (BHTG) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index.
BioHiTech Global, Inc. (BHTG) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
12/29/2020Upgraded
BioHiTech Global, Inc. (BHTG) was upgraded to D from D- on 12/29/2020 due to an increase in the total return index.
BioHiTech Global, Inc. (BHTG) was upgraded to D from D- on 12/29/2020 due to an increase in the total return index.
D
Sell
12/7/2020Downgrade
BioHiTech Global, Inc. (BHTG) was downgraded to D- from D on 12/7/2020 due to a decline in the total return index.
BioHiTech Global, Inc. (BHTG) was downgraded to D- from D on 12/7/2020 due to a decline in the total return index.
D
Sell
11/20/2020Upgraded
BioHiTech Global, Inc. (BHTG) was upgraded to D from D- on 11/20/2020 due to an increase in the growth index, solvency index and valuation index. Debt to equity declined from -5.09 to -23.32, the quick ratio increased from 0.17 to 0.42, and earnings per share increased from -$0.1646 to -$0.1597.
BioHiTech Global, Inc. (BHTG) was upgraded to D from D- on 11/20/2020 due to an increase in the growth index, solvency index and valuation index. Debt to equity declined from -5.09 to -23.32, the quick ratio increased from 0.17 to 0.42, and earnings per share increased from -$0.1646 to -$0.1597.
D
Sell
8/14/2020Downgrade
BioHiTech Global, Inc. (BHTG) was downgraded to D- from D on 8/14/2020 due to a significant decline in the efficiency index, solvency index and growth index. The quick ratio declined from 0.25 to 0.17, debt to equity increased from -7.28 to -5.07, and total revenue declined 6.28% from $1.36M to $1.27M.
BioHiTech Global, Inc. (BHTG) was downgraded to D- from D on 8/14/2020 due to a significant decline in the efficiency index, solvency index and growth index. The quick ratio declined from 0.25 to 0.17, debt to equity increased from -7.28 to -5.07, and total revenue declined 6.28% from $1.36M to $1.27M.
D
Sell
11/20/2019Downgrade
BioHiTech Global, Inc. (BHTG) was downgraded to D from D+ on 11/20/2019 due to a decline in the growth index. Operating cash flow declined 395.85% from -$806.4 to -$4M.
BioHiTech Global, Inc. (BHTG) was downgraded to D from D+ on 11/20/2019 due to a decline in the growth index. Operating cash flow declined 395.85% from -$806.4 to -$4M.
D
Sell
9/12/2019Upgraded
BioHiTech Global, Inc. (BHTG) was upgraded to D+ from D on 9/12/2019 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 42.5% from $737.7 to $1.05M, operating cash flow increased 33.5% from -$1.21M to -$806.4, and the quick ratio increased from 0.23 to 0.23.
BioHiTech Global, Inc. (BHTG) was upgraded to D+ from D on 9/12/2019 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 42.5% from $737.7 to $1.05M, operating cash flow increased 33.5% from -$1.21M to -$806.4, and the quick ratio increased from 0.23 to 0.23.
D
Sell
4/25/2018Downgrade
BioHiTech Global, Inc. (BHTG) was downgraded to D from D+ on 4/25/2018 due to a decline in the total return index and volatility index.
BioHiTech Global, Inc. (BHTG) was downgraded to D from D+ on 4/25/2018 due to a decline in the total return index and volatility index.
D
Sell
4/10/2018Upgraded
BioHiTech Global, Inc. (BHTG) was upgraded to D+ from D on 4/10/2018 due to a noticeable increase in the growth index, solvency index and valuation index. The quick ratio increased from 0.1 to 0.35, operating cash flow increased 44.32% from -$1.68M to -$936.9, and debt to equity declined from -1.03 to -1.33.
BioHiTech Global, Inc. (BHTG) was upgraded to D+ from D on 4/10/2018 due to a noticeable increase in the growth index, solvency index and valuation index. The quick ratio increased from 0.1 to 0.35, operating cash flow increased 44.32% from -$1.68M to -$936.9, and debt to equity declined from -1.03 to -1.33.
D
Sell
11/16/2017Downgrade
BioHiTech Global, Inc. (BHTG) was downgraded to D from D+ on 11/16/2017 due to a large decline in the total return index.
BioHiTech Global, Inc. (BHTG) was downgraded to D from D+ on 11/16/2017 due to a large decline in the total return index.
D
Sell
10/20/2017None
Renovare Environmental, Inc. (RENO) was downgraded to D+ from U on 10/20/2017.
Renovare Environmental, Inc. (RENO) was downgraded to D+ from U on 10/20/2017.
OTC PK
03/12/2025 11:25AM Eastern
Quotes delayed
